Abiraterone in Metastatic Prostate Cancer without Previous ChemotherapyCharles J. Ryan, Dana E. Rathkopf, Joan Carles et al.|New England Journal of Medicine|2012Cited by 2.8k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Andrew J. Armstrong, Michael J. Morris et al.|Journal of Clinical Oncology|2016Cited by 1.6k
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J. Armstrong, Daniel J. George, Susan Halabi et al.|Journal of Clinical Oncology|2019Cited by 364
Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancerTian Zhang, Andrew J. Armstrong, Anika Agarwal et al.|Biomarker Research|2021Cited by 49
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancerAndrew J. Armstrong, Daniel J. George, Santosh Gupta et al.|PLoS ONE|2019Cited by 17